GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jeevan Scientific Technology Ltd (BOM:538837) » Definitions » Total Assets

Jeevan Scientific Technology (BOM:538837) Total Assets : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Jeevan Scientific Technology Total Assets?

Jeevan Scientific Technology's Total Assets for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

During the past 12 months, Jeevan Scientific Technology's average Total Assets Growth Rate was 15.10% per year. During the past 3 years, the average Total Assets Growth Rate was 4.00% per year. During the past 5 years, the average Total Assets Growth Rate was 2.80% per year. During the past 10 years, the average Total Assets Growth Rate was 20.10% per year.

During the past 13 years, Jeevan Scientific Technology's highest 3-Year average Total Assets Growth Rate was 57.60%. The lowest was -5.80%. And the median was 17.75%.

Total Assets is connected with ROA %. Jeevan Scientific Technology's annualized ROA % for the quarter that ended in Dec. 2024 was 0.57%. Total Assets is also linked to Revenue through Asset Turnover. Jeevan Scientific Technology's Asset Turnover for the quarter that ended in Dec. 2024 was 0.17.


Jeevan Scientific Technology Total Assets Historical Data

The historical data trend for Jeevan Scientific Technology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeevan Scientific Technology Total Assets Chart

Jeevan Scientific Technology Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 538.76 659.78 778.79 659.23 678.66

Jeevan Scientific Technology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 678.66 - 731.40 -

Jeevan Scientific Technology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Jeevan Scientific Technology's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=486.31+192.346
=678.7

Jeevan Scientific Technology's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=N/A+N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jeevan Scientific Technology  (BOM:538837) Total Assets Explanation

Total Assets is connected with ROA %.

Jeevan Scientific Technology's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=4.2/( (731.402+0)/ 1 )
=4.2/731.402
=0.57 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Jeevan Scientific Technology's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=125.072/( (731.402+0)/ 1 )
=125.072/731.402
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Jeevan Scientific Technology Total Assets Related Terms

Thank you for viewing the detailed overview of Jeevan Scientific Technology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jeevan Scientific Technology Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 1&2, Sai Krupa Enclave, Manikonda Jagir, Near Lanco Hills, Golconda Post, Hyderabad, TG, IND, 500008
Jeevan Scientific Technology Ltd is an India based company engaged in providing Clinical research and data management services. Jeevan Scientific is an Independent Clinical Contract Research Organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various Clients across the globe. Its services offer high-value, advanced testing services, including bioanalytical services for small - large molecules ranging across Generics, Biosimilars, and other new drugs. It operates in a single segment namely Clinical Research Services.

Jeevan Scientific Technology Headlines

No Headlines